Available from: Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
We are committed to demystifying semaglutide costs and insurance benefits, allowing you to make informed decisions about beginning your treatment
If you experience any unusual neurological symptoms, report them to your healthcare professional
doi: 10.3389/fendo.2023.1217165
The choice should depend on your clinical profile, medical history, insurance coverage, and provider recommendation rather than cost alone
The test costs $99 as an add-on after your first month